Patent ID: 6033364
Filing Date: 2000-03-07
Classification: C12Q,G01N,G16H

Abstract:
A method of determining if reperfusion has occurred in a myocardial infarct patient after receiving thrombolytic therapy, comprising:(a) detecting a first variable comprising a first serum creatine kinase MB level in a myocardial infarct patient undergoing thrombolytic therapy at the an onset of said thrombolytic therapy; then(b) detecting a second variable comprising a second creatine kinase MB level in said patient a predetermined time after the onset of said thrombolytic therapy; and(c) detecting a third variable comprising a presence or absence of chest pain a predetermined time after the onset of said thrombolytic therapy;(d) detecting a fourth variable comprising a serum myoglobin level in said patient a predetermined time after the onset of said thrombolytic therapy;(e) generating a probability of the presence of a persistent occlusion from said first through fourth variables, the absence of a persistent occlusion indicating that reperfusion has occurred in said patient.